Strides Pharma Science Limited considered and approved offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, Non-Convertible Debentures (NCDs) of face value INR 10,00,000 each aggregating up to INR 1500 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
843 INR | +1.17% | -4.91% | +29.85% |
05-10 | Market Heavyweights Lifts Indian Equities to End Week Higher | MT |
05-10 | Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.85% | 928M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Limited Approves Offering for Subscription Up to 1,500 Senior, Secured, Rated, Unlisted, Redeemable, Non-Convertible Debentures